
Allen Chan
Examiner (ID: 15172, Phone: (571)270-5529 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3715, 3718, 3714 |
| Total Applications | 950 |
| Issued Applications | 686 |
| Pending Applications | 57 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9149084
[patent_doc_number] => 20130303607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'Triterpenoids and Compositions Containing the Same'
[patent_app_type] => utility
[patent_app_number] => 13/466456
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9202
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466456
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/466456 | Triterpenoids and compositions containing the same | May 7, 2012 | Issued |
Array
(
[id] => 8483822
[patent_doc_number] => 20120283228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => '2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/463557
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 39622
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463557 | 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses | May 2, 2012 | Abandoned |
Array
(
[id] => 8442321
[patent_doc_number] => 20120258938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/460375
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 82
[patent_no_of_words] => 46392
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/460375 | Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof | Apr 29, 2012 | Abandoned |
Array
(
[id] => 8465650
[patent_doc_number] => 20120270817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => '6-Substituted Estradiol Derivatives and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/459665
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17619
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13459665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/459665 | 6-substituted estradiol derivatives and methods of use | Apr 29, 2012 | Issued |
Array
(
[id] => 10567290
[patent_doc_number] => 09290447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => '(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses'
[patent_app_type] => utility
[patent_app_number] => 13/451317
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 6668
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451317
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/451317 | (20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses | Apr 18, 2012 | Issued |
Array
(
[id] => 8442322
[patent_doc_number] => 20120258939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'PHARMACEUTICAL MANUFACTURING PROCESS'
[patent_app_type] => utility
[patent_app_number] => 13/447468
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6215
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447468 | PHARMACEUTICAL MANUFACTURING PROCESS | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8312532
[patent_doc_number] => 20120189556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS'
[patent_app_type] => utility
[patent_app_number] => 13/433778
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7681
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433778
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433778 | PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS | Mar 28, 2012 | Abandoned |
Array
(
[id] => 8990621
[patent_doc_number] => 20130217902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR INHIBITING MAMMALIAN TUMOR CELL PROLIFERATION'
[patent_app_type] => utility
[patent_app_number] => 13/430703
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11092
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430703
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/430703 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR INHIBITING MAMMALIAN TUMOR CELL PROLIFERATION | Mar 26, 2012 | Abandoned |
Array
(
[id] => 9384571
[patent_doc_number] => 20140088053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD10'
[patent_app_type] => utility
[patent_app_number] => 14/007577
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 58889
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007577 | Inhibitors of 17b-HSD1, 17b-HSD3 and 17b-HSD10 | Mar 25, 2012 | Issued |
Array
(
[id] => 9331297
[patent_doc_number] => 20140058079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/006842
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11982
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006842 | DERIVATIVES OF ALLOPREGNANOLONE AND OF EPIALLOPREGNANOLONE AND USES THEREOF FOR TREATING A NEUROPATHOLOGICAL CONDITION | Mar 22, 2012 | Abandoned |
Array
(
[id] => 8402266
[patent_doc_number] => 20120234316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'ISOXAZOLIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/421150
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57763
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421150
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421150 | ISOXAZOLIDINE DERIVATIVES | Mar 14, 2012 | Abandoned |
Array
(
[id] => 8406462
[patent_doc_number] => 20120238531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'ISOXAZOLIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/421128
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18887
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421128
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421128 | Isoxazolidine derivatives | Mar 14, 2012 | Issued |
Array
(
[id] => 8290403
[patent_doc_number] => 20120178726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/417626
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80271
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417626
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/417626 | NOVEL COMPOUNDS | Mar 11, 2012 | Abandoned |
Array
(
[id] => 9971183
[patent_doc_number] => 09018194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Vitamin D receptor modulators with partial agonist activity'
[patent_app_type] => utility
[patent_app_number] => 14/002502
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10468
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002502 | Vitamin D receptor modulators with partial agonist activity | Feb 29, 2012 | Issued |
Array
(
[id] => 8586875
[patent_doc_number] => 20130005696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/508827
[patent_app_country] => US
[patent_app_date] => 2012-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15720
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508827
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508827 | BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF | Feb 19, 2012 | Abandoned |
Array
(
[id] => 9888992
[patent_doc_number] => 08975246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-10
[patent_title] => 'Bile acid or bile salt fatty acid conjugates'
[patent_app_type] => utility
[patent_app_number] => 13/366796
[patent_app_country] => US
[patent_app_date] => 2012-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4069
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13366796
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/366796 | Bile acid or bile salt fatty acid conjugates | Feb 5, 2012 | Issued |
Array
(
[id] => 8301044
[patent_doc_number] => 20120183603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'INHIBITORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/364121
[patent_app_country] => US
[patent_app_date] => 2012-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 39056
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364121 | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto | Jan 31, 2012 | Issued |
Array
(
[id] => 8649589
[patent_doc_number] => 20130035318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/359727
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140950
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13359727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359727 | C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity | Jan 26, 2012 | Issued |
Array
(
[id] => 9345058
[patent_doc_number] => 08664206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3'
[patent_app_type] => utility
[patent_app_number] => 13/344987
[patent_app_country] => US
[patent_app_date] => 2012-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 27
[patent_no_of_words] => 26854
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/344987 | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 | Jan 5, 2012 | Issued |
Array
(
[id] => 8160201
[patent_doc_number] => 20120101070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => '11a, 12-Derivatives of Tetracycline Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/340040
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16715
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101070.pdf
[firstpage_image] =>[orig_patent_app_number] => 13340040
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/340040 | 11a, 12-derivatives of tetracycline compounds | Dec 28, 2011 | Issued |